BIOA:US
$4.52
0.668%

BioAge Labs Inc.
News & Events

Last updated: Jun 14, 2025, 5:19 AM ET

  1. BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates

    GlobeNewswire JUN 3, 2025 9:00 AM EDT
    Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody...
    READ ARTICLE
  2. BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

    GlobeNewswire MAY 29, 2025 9:00 AM EDT
    IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102...
    READ ARTICLE
  3. BioAge Labs to Present at Upcoming Investor Conferences

    GlobeNewswire MAY 27, 2025 4:30 PM EDT
    EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", ...
    READ ARTICLE
  4. BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    GlobeNewswire MAY 21, 2025 9:00 PM EDT
    NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recogniz...
    READ ARTICLE
  5. BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

    GlobeNewswire MAY 6, 2025 4:30 PM EDT
    Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with...
    READ ARTICLE
  6. Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf

    GlobeNewswire APR 24, 2025 8:28 AM EDT
    PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ...
    READ ARTICLE
  7. Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf

    GlobeNewswire APR 22, 2025 8:13 AM EDT
    PHILADELPHIA, April 22, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ...
    READ ARTICLE
  8. Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)

    GlobeNewswire APR 17, 2025 7:31 AM EDT
    PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ...
    READ ARTICLE
  9. BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

    GlobeNewswire MAR 20, 2025 4:30 PM EDT
    Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected...
    READ ARTICLE
  10. BioArctic receives Orphan Drug Designation for exidavnemab the US

    PR Newswire MAR 17, 2025 1:49 PM EDT
    BioArctic receives Orphan Drug Designation for exidavnemab the US PR Newswire ...
    READ ARTICLE

Upcoming Events

Get notified of BioAge Labs Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement (Unconfirmed)

    Aug 5, 2025
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available